Investors & Media

Sangamo Therapeutics is a genomic medicine company that pioneered the development of zinc finger and capsid delivery technologies to address serious neurological and rare diseases. The Company is currently operating under court supervision in Chapter 11. To learn more, visit https://www.veritaglobal.net/SangamoTherapeutics.

 

Stock Quote

Minimum 15 minutes delayed. Source: LSEG

Latest News Releases

Filing date Form Description Filing Group View
SCHEDULE 13G/A SCHEDULE 13G/A - Description
Other
View HTML
8-K Report of unscheduled material events or corporate event
Current Reports
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-K Report of unscheduled material events or corporate event
Current Reports
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Upcoming Events
  • More events are coming soon.
Past Events

Contacts